Literature DB >> 10532808

Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development.

J T Lu1, Y J Son, J Lee, T L Jetton, M Shiota, L Moscoso, K D Niswender, A D Loewy, M A Magnuson, J R Sanes, R B Emeson.   

Abstract

alpha-Calcitonin gene-related peptide (alphaCGRP) is a pleiotropic peptide neuromodulator that is widely expressed throughout the Central and peripheral nervous systems. CGRP has been implicated in a variety of physiological processes including peripheral vasodilation, cardiac acceleration nicotinic acetylcholine receptor (AChR) synthesis and function, testicular descent, nociception, carbohydrate metabolism, gastrointestinal motility, neurogenic inflammation, and gastric acid secretion. To provide a better understanding of the physiological role(s) mediated by this peptide neurotransmitter, we have generated alphaCGRP-null mice by targeted modification in embryonic stem cells. Mice lacking alpha CGRP expression demonstrate no obvious phenotypic differences from their wild-type littermates. Detailed analysis of systemic cardiovascular function revealed no differences between control and mutant mice regarding heart rate and blood pressure under basal or exercise-induced conditions and subsequent to pharmacological manipulation. Characterization of neuromuscular junction in morphology including nicotinic receptor localization, terminal sprouting in response to denervation, developmental regulation of AChR subunit expression, and synapse elimination also revealed no differences in alphaCGRP-deficient animals. These results suggest that alphaCGRP is not required for the systemic regulation of cardiovascular hemodynamics or development of the neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10532808     DOI: 10.1006/mcne.1999.0767

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  34 in total

1.  Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene.

Authors:  Ana O Hoff; Philip Catala-Lehnen; Pamela M Thomas; Matthias Priemel; Johannes M Rueger; Igor Nasonkin; Allan Bradley; Mark R Hughes; Nelson Ordonez; Gilbert J Cote; Michael Amling; Robert F Gagel
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Efferent innervation of turtle semicircular canal cristae: comparisons with bird and mouse.

Authors:  Paivi M Jordan; Margaret Fettis; Joseph C Holt
Journal:  J Comp Neurol       Date:  2015-03-25       Impact factor: 3.215

3.  Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.

Authors:  Hiroyuki Nagashima; Tanel Mahlakõiv; Han-Yu Shih; Fred P Davis; Francoise Meylan; Yuefeng Huang; Oliver J Harrison; Chen Yao; Yohei Mikami; Joseph F Urban; Kathleen M Caron; Yasmine Belkaid; Yuka Kanno; David Artis; John J O'Shea
Journal:  Immunity       Date:  2019-07-25       Impact factor: 31.745

4.  Involvement of Receptor Activity-Modifying Protein 3 (RAMP3) in the Vascular Actions of Adrenomedullin in Rat Mesenteric Artery Smooth Muscle Cells.

Authors:  Madhu Chauhan; Uma Yallampalli; Manu Banadakappa; Chandrasekhar Yallampalli
Journal:  Biol Reprod       Date:  2015-09-30       Impact factor: 4.285

5.  Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.

Authors:  J B Pawlak; S E Wetzel-Strong; M K Dunn; K M Caron
Journal:  Peptides       Date:  2016-12-08       Impact factor: 3.750

6.  Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene.

Authors:  Ryan T Dackor; Kimberly Fritz-Six; William P Dunworth; Carrie L Gibbons; Oliver Smithies; Kathleen M Caron
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice.

Authors:  Kazutake Tsujikawa; Katsutoshi Yayama; Tamon Hayashi; Hiroaki Matsushita; Taijiro Yamaguchi; Tomomi Shigeno; Yusuke Ogitani; Megumi Hirayama; Tetsuya Kato; So-ichiro Fukada; Shingo Takatori; Hiromu Kawasaki; Hiroshi Okamoto; Masahito Ikawa; Masaru Okabe; Hiroshi Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-08       Impact factor: 11.205

8.  Loss of α-calcitonin gene-related peptide (αCGRP) reduces the efficacy of the Vestibulo-ocular Reflex (VOR).

Authors:  Anne E Luebke; Joseph C Holt; Paivi M Jordan; Yi Shan Wong; Jillian S Caldwell; Kathleen E Cullen
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

9.  Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis.

Authors:  Claudia Sardi; Laura Zambusi; Annamaria Finardi; Francesca Ruffini; Adviye A Tolun; Ian M Dickerson; Marco Righi; Daniele Zacchetti; Fabio Grohovaz; Luciano Provini; Roberto Furlan; Stefano Morara
Journal:  J Neuroimmunol       Date:  2014-03-19       Impact factor: 3.478

10.  Calcitonin gene-related peptide (CGRP) in autonomic cardiovascular regulation and vascular structure.

Authors:  Tu H Mai; Jing Wu; André Diedrich; Emily M Garland; David Robertson
Journal:  J Am Soc Hypertens       Date:  2014-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.